These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1343 related articles for article (PubMed ID: 31060544)

  • 41. Laparoscopic Hyperthermic Intraperitoneal Chemotherapy is Safe for Patients with Peritoneal Metastases from Gastric Cancer and May Lead to Gastrectomy.
    Newhook TE; Agnes A; Blum M; Estrella JS; Das P; Ho L; Ajani JA; Minsky BD; Mansfield P; Badgwell BD
    Ann Surg Oncol; 2019 May; 26(5):1394-1400. PubMed ID: 30680477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Goblet Cell Carcinoma: A Prospective Cohort Study.
    Madsen AH; Ladekarl M; Villadsen GE; Grønbæk H; Sørensen MM; Stribolt K; Verwaal VJ; Iversen LH
    Ann Surg Oncol; 2018 Feb; 25(2):422-430. PubMed ID: 29214450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of neoadjuvant chemotherapy combined with prophylactic intraperitoneal hyperthermic chemotherapy for patients diagnosed with clinical T4 gastric cancer who underwent laparoscopic radical gastrectomy: a retrospective cohort study based on propensity score matching.
    Lv CB; Tong LY; Zeng WM; Chen QX; Fang SY; Sun YQ; Cai LS
    World J Surg Oncol; 2024 Sep; 22(1):244. PubMed ID: 39256787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer.
    Marrelli D; Petrioli R; Cassetti D; D'Ignazio A; Marsili S; Mazzei MA; Lazzi S; Roviello F
    Surg Oncol; 2021 Jun; 37():101523. PubMed ID: 33545658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients.
    Costa WL; Coimbra FJ; Ribeiro HS; Diniz AL; de Godoy AL; Begnami M; Silva MJ; Fanelli MF; Mello CA
    World J Surg Oncol; 2012 Sep; 10():195. PubMed ID: 22992263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial.
    Klaver CEL; Wisselink DD; Punt CJA; Snaebjornsson P; Crezee J; Aalbers AGJ; Brandt A; Bremers AJA; Burger JWA; Fabry HFJ; Ferenschild F; Festen S; van Grevenstein WMU; Hemmer PHJ; de Hingh IHJT; Kok NFM; Musters GD; Schoonderwoerd L; Tuynman JB; van de Ven AWH; van Westreenen HL; Wiezer MJ; Zimmerman DDE; van Zweeden AA; Dijkgraaf MGW; Tanis PJ;
    Lancet Gastroenterol Hepatol; 2019 Oct; 4(10):761-770. PubMed ID: 31371228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery in colorectal carcinoma at high risk of peritoneal carcinomatosis: short-term and long-term outcomes from the CHECK study - protocol for a randomised, multicentre, phase 3 trial.
    Pacelli F; Gerardi C; Rulli E; Abatini C; Rotolo S; Garattini S; Melotti G; Torri V; Galli F; Rulli E; Di Giorgio A;
    BMJ Open; 2022 Aug; 12(8):e051324. PubMed ID: 35914916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgical Options for Peritoneal Surface Metastases from Digestive Malignancies-A Comprehensive Review.
    Eftimie MA; Potlog G; Alexandrescu ST
    Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Japanese practice of comprehensive treatment for peritoneal metastasis of gastric cancer].
    Liu Y; Yutaka CL; Toshiyuki LX; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Oct; 26(10):992-996. PubMed ID: 37849272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent.
    Yonemura Y; Canbay E; Li Y; Coccolini F; Glehen O; Sugarbaker PH; Morris D; Moran B; Gonzaletz-Moreno S; Deraco M; Piso P; Elias D; Batlett D; Ishibashi H; Mizumoto A; Verwaal V; Mahtem H
    Eur J Surg Oncol; 2016 Aug; 42(8):1123-31. PubMed ID: 27160355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    van Eden WJ; Kok NF; Jóźwiak K; Lahaye ML; Beets GL; van Leerdam ME; Boot H; Aalbers AG
    Dis Colon Rectum; 2017 May; 60(5):477-487. PubMed ID: 28383447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial.
    Quénet F; Elias D; Roca L; Goéré D; Ghouti L; Pocard M; Facy O; Arvieux C; Lorimier G; Pezet D; Marchal F; Loi V; Meeus P; Juzyna B; de Forges H; Paineau J; Glehen O;
    Lancet Oncol; 2021 Feb; 22(2):256-266. PubMed ID: 33476595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial.
    de Boer NL; Brandt-Kerkhof ARM; Madsen EVE; Diepeveen M; van Meerten E; van Eerden RAG; de Man FM; Bouamar R; Koolen SLW; de Hingh IHJT; Bakkers C; Rovers KP; Creemers GM; Deenen MJ; Kranenburg OW; Constantinides A; Mathijssen RHJ; Verhoef C; Burger JWA; ;
    BMJ Open; 2019 Dec; 9(12):e034508. PubMed ID: 31818845
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.
    Amblard I; Mercier F; Bartlett DL; Ahrendt SA; Lee KW; Zeh HJ; Levine EA; Baratti D; Deraco M; Piso P; Morris DL; Rau B; Tentes AAK; Tuech JJ; Quenet F; Akaishi E; Pocard M; Yonemura Y; Lorimier G; Delroeux D; Villeneuve L; Glehen O; Passot G;
    Eur J Surg Oncol; 2018 Sep; 44(9):1378-1383. PubMed ID: 30131104
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Phase II Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Gastric Cancer and Carcinomatosis or Positive Cytology.
    Badgwell B; Ikoma N; Murphy MB; Wang X; Estrella J; Roy-Chowdhuri S; Das P; Minsky BD; Lano E; Song S; Mansfield P; Ajani J
    Ann Surg Oncol; 2021 Jan; 28(1):258-264. PubMed ID: 32556731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Perioperative Management of Gastric Cancer Patients Treated With (Sub)Total Gastrectomy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Lessons Learned.
    Koemans WJ; Houwink A; van der Kaaij RT; Wassenaar ECE; Boerma D; Hahn C; Imhof O; Brandt MG; Ariëns MP; Veenhof AAFA; Hartemink KJ; van Sandick JW
    Ann Surg Oncol; 2021 Aug; 28(8):4647-4654. PubMed ID: 33389293
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of hyperthermic intraperitoneal chemotherapy in combination with cytoreductive surgery on the prognosis of patients with colorectal cancer peritoneal metastasis: a systematic review and meta-analysis.
    Li J; Wang AR; Chen XD; Zhang YX; Pan H; Li SQ
    World J Surg Oncol; 2022 Jun; 20(1):200. PubMed ID: 35701802
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of diagnostic laparoscopy in patients with suspicion of colorectal peritoneal metastases to evaluate suitability for cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Hentzen JEKR; van der Plas WY; Constansia RDN; Been LB; Hoogwater FJH; van Ginkel RJ; van Dam GM; Hemmer PHJ; Kruijff S
    BJS Open; 2019 Dec; 3(6):812-821. PubMed ID: 31832588
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recurrence and Survival Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Small Bowel Adenocarcinoma.
    Saxena A; Valle SJ; Liauw W; Morris DL
    Anticancer Res; 2017 Oct; 37(10):5737-5742. PubMed ID: 28982894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
    Wu HT; Yang XJ; Huang CQ; Sun JH; Ji ZH; Peng KW; Zhang Q; Li Y
    World J Surg Oncol; 2016 Sep; 14(1):246. PubMed ID: 27633880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 68.